Waste Management (WM) Q4 2025 earnings review
Entering the 'Harvest' Phase: Margins and Cash Flow Surge
WM delivered a thesis-affirming quarter, signaling a transition from heavy investment to a 'harvest' phase. While top-line growth (+7.1%) was solid, the real story is profitability and cash flow. Management's focus on cost discipline pushed Legacy Business operating expenses below 60% of revenue—a historic best. Simultaneously, the newly integrated Healthcare Solutions segment saw adjusted EBITDA margins rocket to 17.1% from near-zero a year ago. The bullishness culminates in FY26 guidance: Free Cash Flow is projected to jump nearly 30% to ~$3.8B, fueling a resumption of share buybacks ($2B) and a dividend hike.
🐂 Bull Case
Doubts about the Stericycle acquisition are evaporating. Healthcare Solutions adjusted EBITDA margin expanded to 17.1% in Q4 (up 180bps sequentially and from 1.0% in the prior year comparable), validating the synergy capture.
With capital intensity peaking in 2025, WM is unlocking cash. Guidance for 2026 implies ~$3.8B in FCF (+30% YoY), enabling $2B in buybacks and a double-digit dividend increase.
🐻 Bear Case
Growth is almost entirely price-driven. Core Collection & Disposal volume was effectively flat (+0.1%), masking weakness with price hikes. If pricing power wanes, organic growth evaporates.
Recycled commodity prices plummeted to ~$62/ton in Q4 from ~$87/ton a year ago. This creates a drag on the Sustainability segment, which is sensitive to market pricing despite automation efforts.
⚖️ Verdict: 🟢🟢
Strong Bullish. WM is executing perfectly on the 'price-over-volume' strategy while successfully integrating a massive acquisition. The projected 30% jump in FCF for 2026 changes the investment profile significantly.
Key Themes
Operational Excellence & Margin Expansion
WM is structurally lowering its cost base. Legacy Business operating expenses as a percentage of revenue improved 150 basis points to 58.0% in Q4. Investments in fleet automation and labor retention are paying off, allowing EBITDA growth (+15.5%) to significantly outpace revenue growth (+7.1%).
Healthcare Solutions Profitability Spike
The integration of the Healthcare Solutions (formerly Stericycle) business is accelerating. Adjusted EBITDA margin hit 17.1% in Q4 2025, up from 15.3% in Q1 and just ~1.0% in the prior year period. Synergies and cost optimization are materializing faster than anticipated, turning a low-margin asset into a contributor approaching corporate average profitability.
Reliance on Price Over Volume
Revenue quality is skewed heavily toward pricing. In the Legacy Business, Core Price was +6.3% and Yield +3.8%, while Volume was a meager +0.1%. While this demonstrates immense pricing power, the lack of volume growth suggests underlying demand is tepid or the company is shedding too many customers to maintain margins.
Recycling Commodity Pricing Deflation
The Sustainability segment is fighting significant headwinds. Blended average commodity prices dropped to $62/ton in Q4 2025 from $87/ton in Q4 2024 (-29%). While automation helps, this volatility creates a persistent drag on the top line of the Recycling Processing segment.
Capital Allocation Reset
After a pause to digest acquisitions and deleverage, WM is aggressively returning capital. The plan to repurchase $2B in shares in 2026, alongside a dividend hike to $3.78/share, signals management's confidence in the balance sheet and future cash generation.
Other KPIs
Stable. Up 7.1% YoY, driven primarily by the Healthcare acquisition and pricing in the legacy business. Organic volume growth remains flat.
Accelerating. Up 240 basis points from 28.9% in 24Q4. This is a significant beat, driven by SG&A leverage and operational efficiency in the legacy fleet.
Accelerating. Up 26.8% YoY. This sets the stage for the massive jump guided for 2026.
Guidance
Accelerating. The midpoint implies ~29% YoY growth from 2025. This is the standout metric, driven by reduced capital intensity (down ~$100M) and EBITDA growth.
Stable. Implies ~6.2% growth on a comparable basis. The growth rate is solid but notably lower than the 15% growth seen in 2025 (which included acquisition impacts). Margin expansion is expected to continue (+30-50 bps).
Decelerating. Implies ~5.2% growth, compared to 14.2% in 2025 (acquisition boosted). Core price expectations remain strong at 5.4%-5.8%, but volume expectations remain low (0.2%-0.6%).
Decelerating/Improving. A reduction of ~$100M in support capital and ~$400M in sustainability growth capital vs 2025. This reduction is the primary lever for the FCF explosion.
Key Questions
Volume vs. Price Sustainability
With volume growth effectively flat (0.1%) and core pricing at 6.3%, are we reaching a ceiling on price hikes? At what point does the strategy shift to prioritizing volume to sustain top-line growth?
Healthcare Margin Ceiling
Healthcare Solutions margin improved rapidly to ~17%. Is this the stabilized run-rate, or is there further expansion room towards the Legacy Business margin profile of ~30%?
Commodity Price Outlook
Guidance assumes recycled commodity prices of ~$70/ton. With Q4 exiting at $62/ton, does 2026 guidance rely on a market recovery that hasn't happened yet?
AI Implementation
You mentioned 'managing benefits and risks of AI' in forward-looking statements. Are there specific near-term capital projects related to AI in fleet routing or customer service that are included in the 2026 capex budget?